These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 28440767)

  • 1. Zinc alpha-2 glycoprotein is overproduced in Cushing's syndrome.
    Escoté X; Aranda GB; Mora M; Casals G; Enseñat J; Vidal O; Esteban Y; Halperin I; Hanzu FA
    Endocrinol Diabetes Nutr; 2017 Jan; 64(1):26-33. PubMed ID: 28440767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating and adipose tissue gene expression of zinc-alpha2-glycoprotein in obesity: its relationship with adipokine and lipolytic gene markers in subcutaneous and visceral fat.
    Ceperuelo-Mallafré V; Näf S; Escoté X; Caubet E; Gomez JM; Miranda M; Chacon MR; Gonzalez-Clemente JM; Gallart L; Gutierrez C; Vendrell J
    J Clin Endocrinol Metab; 2009 Dec; 94(12):5062-9. PubMed ID: 19846741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol].
    Robaczyk MG
    Ann Acad Med Stetin; 2002; 48():283-300. PubMed ID: 14601484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum zinc-alpha2-glycoprotein correlates with adiposity, triglycerides, and the key components of the metabolic syndrome in Chinese subjects.
    Yeung DC; Lam KS; Wang Y; Tso AW; Xu A
    J Clin Endocrinol Metab; 2009 Jul; 94(7):2531-6. PubMed ID: 19351730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of glucocorticoids on adiponectin: a study in healthy subjects and in Cushing's syndrome.
    Fallo F; Scarda A; Sonino N; Paoletta A; Boscaro M; Pagano C; Federspil G; Vettor R
    Eur J Endocrinol; 2004 Mar; 150(3):339-44. PubMed ID: 15012619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zinc alpha-2 glycoprotein is implicated in dyslipidaemia in HIV-1-infected patients treated with antiretroviral drugs.
    Ceperuelo-Mallafré V; Escoté X; Viladés C; Peraire J; Domingo P; Solano E; Sirvent JJ; Pastor R; Tinahones F; Leal M; Richart C; Vendrell J; Vidal F; ; Alba V; Aguilar A; Auguet T; Chacón MR; López-Dupla M; Megia A; Miranda M; Olona M; Saurí A; Vargas M; Velasco I; Veloso S; Fontanet A; Gutiérrez M; Mateo G; Muñoz J; Sambeat MA
    HIV Med; 2012 May; 13(5):297-303. PubMed ID: 22256965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is diabetes in Cushing's syndrome only a consequence of hypercortisolism?
    Giordano C; Guarnotta V; Pivonello R; Amato MC; Simeoli C; Ciresi A; Cozzolino A; Colao A
    Eur J Endocrinol; 2014 Feb; 170(2):311-9. PubMed ID: 24255133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum adipokine zinc α2-glycoprotein and lipolysis in cachectic and noncachectic heart failure patients: relationship with neurohormonal and inflammatory biomarkers.
    Tedeschi S; Pilotti E; Parenti E; Vicini V; Coghi P; Montanari A; Regolisti G; Fiaccadori E; Cabassi A
    Metabolism; 2012 Jan; 61(1):37-42. PubMed ID: 21696792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zinc-α2-glycoprotein is associated with insulin resistance in humans and is regulated by hyperglycemia, hyperinsulinemia, or liraglutide administration: cross-sectional and interventional studies in normal subjects, insulin-resistant subjects, and subjects with newly diagnosed diabetes.
    Yang M; Liu R; Li S; Luo Y; Zhang Y; Zhang L; Liu D; Wang Y; Xiong Z; Boden G; Chen S; Li L; Yang G
    Diabetes Care; 2013 May; 36(5):1074-82. PubMed ID: 23275352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adipokine levels in Cushing's syndrome; elevated resistin levels in female patients with Cushing's syndrome.
    Krsek M; Silha JV; Jezková J; Hána V; Marek J; Weiss V; Stepán JJ; Murphy LJ
    Clin Endocrinol (Oxf); 2004 Mar; 60(3):350-7. PubMed ID: 15009001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor Increases Circulating Zinc-Α2-Glycoprotein Levels in Patients with Type 2 Diabetes.
    Liao X; Wang X; Li H; Li L; Zhang G; Yang M; Yuan L; Liu H; Yang G; Gao L
    Sci Rep; 2016 Sep; 6():32887. PubMed ID: 27611858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcutaneous adipose tissue zinc-α2-glycoprotein is associated with adipose tissue and whole-body insulin sensitivity.
    Balaz M; Vician M; Janakova Z; Kurdiova T; Surova M; Imrich R; Majercikova Z; Penesova A; Vlcek M; Kiss A; Belan V; Klimes I; Olejnik J; Gasperikova D; Wolfrum C; Ukropcova B; Ukropec J
    Obesity (Silver Spring); 2014 Aug; 22(8):1821-9. PubMed ID: 24753506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The adipokine zinc-alpha2-glycoprotein (ZAG) is downregulated with fat mass expansion in obesity.
    Mracek T; Ding Q; Tzanavari T; Kos K; Pinkney J; Wilding J; Trayhurn P; Bing C
    Clin Endocrinol (Oxf); 2010 Mar; 72(3):334-41. PubMed ID: 19549246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zinc-alpha 2-glycoprotein gene expression in adipose tissue is related with insulin resistance and lipolytic genes in morbidly obese patients.
    Garrido-Sánchez L; García-Fuentes E; Fernández-García D; Escoté X; Alcaide J; Perez-Martinez P; Vendrell J; Tinahones FJ
    PLoS One; 2012; 7(3):e33264. PubMed ID: 22442679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The natural logarithm of zinc-α2-glycoprotein/HOMA-IR is a better predictor of insulin sensitivity than the product of triglycerides and glucose and the other lipid ratios.
    Qu C; Zhou X; Yang G; Li L; Liu H; Liang Z
    Cytokine; 2016 Mar; 79():96-102. PubMed ID: 26797477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visceral Adiposity Measurements, Metabolic and Inflammatory Profi le in Obese Patients with and Without Type 2 Diabetes Mellitus: A Crosssectional Analysis.
    Wanderley Rocha DR; Jorge AR; Braulio VB; Arbex AK; Marcadenti A
    Curr Diabetes Rev; 2017; 13(1):11-18. PubMed ID: 26467189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent centripetal fat distribution and metabolic abnormalities in patients in long-term remission of Cushing's syndrome.
    Wagenmakers M; Roerink S; Gil L; Plantinga T; Smit J; Netea-Maier R; Hermus A
    Clin Endocrinol (Oxf); 2015 Feb; 82(2):180-7. PubMed ID: 25323660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The degree of urinary hypercortisolism is not correlated with the severity of cushing's syndrome.
    Guarnotta V; Amato MC; Pivonello R; Arnaldi G; Ciresi A; Trementino L; Citarrella R; Iacuaniello D; Michetti G; Simeoli C; Colao A; Giordano C
    Endocrine; 2017 Feb; 55(2):564-572. PubMed ID: 26965912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leptin levels in relation to body composition and insulin concentration in patients with endogenous Cushing's syndrome compared to controls matched for body mass index.
    Schafroth U; Godang K; Ueland T; Berg JP; Bollerslev J
    J Endocrinol Invest; 2000 Jun; 23(6):349-55. PubMed ID: 10908161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma zinc α2-glycoprotein levels are elevated in smokers and correlated with metabolic syndrome.
    Tsai JS; Chen SC; Huang KC; Lue BH; Lee LT; Chiu TY; Chen CY; Guo FR; Chuang LM
    Eur J Clin Invest; 2015 May; 45(5):452-9. PubMed ID: 25708842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.